| Literature DB >> 26644972 |
Abbas Rezaianzadeh1, Behzad Maghsoudi2, Hamidreza Tabatabaee3, Sareh Keshavarzi3, Zahra Bagheri4, Javad Sajedianfard5, Hamid Gerami2, Javad Rasouli3.
Abstract
Background and Objectives. Cardiovascular diseases are the leading cause of death worldwide, with coronary artery disease being the most common. With increasing numbers of patients, Coronary Artery Bypass Grafting (CABG) has become the most common operation in the world. Respiratory disorder is one of the most prevalent complications of CABG. Thus, weaning off the mechanical ventilation and extubation are of great clinical importance for these patients. Some post-operative problems also relate to the tracheal tube and mechanical ventilation. Therefore, an increase in this leads to an increase in the number of complications, length of hospital stay, and treatment costs. Since a large number of factors affect the post-operative period, the present study aims to identify the predictors of extubation time in CABG patients using casualty network analysis. Method. This longitudinal study was conducted on 800 over 18 year old patients who had undergone CABG surgery in three treatment centers affiliated to Shiraz University of Medical Sciences. The patients' information, including pre-operative, peri-operative, and post-operative variables, was retrospectively extracted from their medical records. Then, the data was comprehensively analyzed through path analysis using MPLUS-7.1 software. Results. The mean of extubation time was 10.27 + 4.39 h. Moreover, extubation time was significantly affected by packed cells during the Cardiopulmonary Bypass (CPB), packed cells after CPB, inotrope use on arrival at ICU, mean arterial pressure 1st ICU, packed cells 1st ICU, platelets 1st ICU, Blood Urea Nitrogen 1st ICU, and hematocrit 1st ICU. Conclusion. Considering all of the factors under investigation, some peri-operative and post-operative factors had significant effects. Therefore, considering the post-operative factors is important for designing a treatment plan and evaluating patients' prognosis.Entities:
Keywords: Coronary Artery Bypass; Extubation; Risk factors
Year: 2015 PMID: 26644972 PMCID: PMC4671154 DOI: 10.7717/peerj.1414
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Relevant pre-, perio- and post-operative data collected for all cases.
| Preoperative data | Perioperative data | Post-operative data |
|---|---|---|
| Sex, Age, Body Mass Index (BMI), Smoking, Addiction, Diabetes Mellitus (DM), Hypertension (HTN), Hyperlipidemia (HLP), Ejection Fraction (EF), Hemoglobin preoperation, chronic obstructive pulmonary diseases (COPD), Hematocrit preoperation, Creatinine preoperation, Blood Urea Nitrogen (BUN) preoperation, prior myocardial infarction (MI) (<30 days) | Anesthesia duration, Operation duration, Mean Arterial Pressure (MAP) pre anesthesia, MAP before cardiopulmonary bypass (CPB), Inotrope use before CPB, Total pump time, Cross clamp time, Urinary output before CPB, Hemofilter volume, Inotrope use during CPB, Inotrope use after CPB, MAP at end of operation, Pack Cell after CPB, Platelet after CPB, activated clotting time/second, Urinary output during CPB, Pack Cell during CPB, Lowest temperature on CPB | Inotrope use arrival to ICU, MAP admission ICU, Urinary output first 1h ICU, Pack Cell 1h ICU, Platelet 1h ICU, Creatinine 1st ICU (arrival to ICU), Blood Urea Nitrogen (BUN) 1st ICU (arrival to ICU), hematocrit 1st ICU (arrival to ICU) |
Baseline quantitative characteristics of the patients and univariate analysis result with extubation time.
| Risk factors | Mean ± SD | Pearson correlation coefficient | |
|---|---|---|---|
| Age | 59.26 ± 11.60 | 0.25 | <0.001 |
| Body Mass Index | 25.75 ± 4.18 | −0.17 | <0.001 |
| Ejection fraction | 49.19 ± 10.51 | −0.09 | 0.01 |
| Hemoglobin preoperation | 11.81 ± 1.78 | −0.07 | 0.07 |
| Hematocrit preoperation | 35.04 ± 5.37 | −0.08 | 0.03 |
| Creatinine preoperation | 1.08 ± 0.35 | 0.12 | 0.00 |
| BUN Preoperation | 17.54 ± 6.29 | 0.20 | <0.001 |
| Anesthesia duration | 4.49 ± 0.73 | 0.08 | 0.02 |
| Operation duration | 3.08 ± 0.70 | 0.06 | 0.12 |
| Mean arterial pressure pre anesthesia | 99.93 ± 14.28 | −0.09 | 0.01 |
| MAP before CPB | 71.25 ± 12.21 | −0.01 | 0.82 |
| Total pump time | 70.38 ± 20.71 | 0.10 | 0.01 |
| Cross clamp time | 40.12 ± 13.55 | 0.03 | 0.39 |
| Urinary output before CPB | 240.54 ± 251.94 | −0.01 | 0.88 |
| Hemofilter volume | 1588.74 ± 776.33 | 0.02 | 0.57 |
| MAP at end of operation | 75.93 ± 9.60 | −0.06 | 0.07 |
| Pack Cell after CPB | 0.48 ± 0.60 | 0.11 | 0.00 |
| Platelet after CPB | 0.06 ± 0.51 | 0.05 | 0.19 |
| Urinary output during CPB | 532.18 ± 394.18 | −0.06 | 0.12 |
| Pack Cell during CPB | 0.88 ± 0.85 | 0.14 | <0.001 |
| Lowest temperature on CPB | 33.04 ± 1.16 | −0.08 | 0.03 |
| MAP admission ICU | 79.48 ± 14.77 | −0.18 | <0.001 |
| MAP on 6h ICU | 79.10 ± 10.67 | −0.15 | <0.001 |
| Urinary output first 6h ICU | 1403.67 ± 614.89 | −0.16 | <0.001 |
| Platelet 1h ICU | 0.25 ± 0.99 | 0.12 | 0.00 |
| Creatinine 1st ICU (arrival to ICU) | 1.00 ± 0.31 | 0.17 | <0.001 |
| BUN 1st ICU (arrival to ICU) | 16.15 ± 5.91 | 0.23 | <0.001 |
| Hct 1st ICU (arrival to ICU) | 31.85 ± 4.37 | −0.15 | <0.001 |
| Extubation hours after arrival in ICU | 10.27 ± 4.39 | – | – |
Notes.
Statistically significant (p-value < 0.05).
Baseline qualitative characteristics of the patients and univariate analysis result with extubation time.
| Risk factors | Mean ± SD | |
|---|---|---|
| Sex (Male/Female) | 10.1 ± 4.18/10.52 ± 4.68 | 0.186 |
| Smoking (yes/no) | 9.87 ± 4.32/10.42 ± 4.40 | 0.116 |
| Addiction (yes/no) | 9.71 ± 4.37/10.37 ± 4.38 | 0.124 |
| Diabetes Mellitus (yes/no) | 10.31 ± 4.62/10.24 ± 4.27 | 0.824 |
| Hypertension (yes/no) | 10.48 ± 4.33/9.91 ± 4.47 | 0.076 |
| Hyperlipidemia (yes/no) | 10.22 ± 4.69/10.31 ± 4.08 | 0.762 |
| Chronic obstructive pulmonary diseases (yes/no) | 10.43 ± 5.03/10.26 ± 4.36 | 0.831 |
| Any arrhythmia (yes/no) | 10.49 ± 4.22/10.24 ± 4.40 | 0.629 |
| MI <30 days (yes/no) | 9.65 ± 4.43/10.35 ± 4.37 | 0.142 |
| Inotrope use before CPB (yes/no) | 13.15 ± 6.33/10.12 ± 4.21 | <0.001 |
| Inotrope use during CPB (yes/no) | 10.89 ± 5.14/9.89 ± 3.83 | 0.002 |
| Inotrope use after CPB (yes/no) | 10.61 ± 4.71/9.68 ± 3.71 | 0.003 |
| Inotrope use arrival to ICU (yes/no) | 10.72 ± 4.67/9.46 ± 3.51 | <0.001 |
| Inotrope use on 6h ICU (yes/no) | 11.83 ± 5.12/ 9.32 ± 3.5 | <0.001 |
Notes.
Statistically significant (p-value < 0.05).
Standardized direct, indirect and total risk factors effects on extubation time.
| Risk factor | Direct effect | Indirect effect | Total effect | |||
|---|---|---|---|---|---|---|
| Sex | 0.014 | 0.779 | 0.056 | 0.011 | 0.070 | 0.123 |
| Diabetes Mellitus | −0.094 | 0.017 | 0.019 | 0.037 | −0.076 | 0.058 |
| Pack Cell during CPB | 0.191 | <0.001 | −0.017 | 0.105 | 0.174 | 0.001 |
| Hemoglobin preoperation | 0.126 | 0.388 | −0.099 | 0.020 | 0.027 | 0.853 |
| Pack Cell after CPB | 0.102 | 0.008 | −0.006 | 0.254 | 0.096 | 0.013 |
| Hypertension | 0.035 | 0.403 | 0.021 | 0.027 | 0.056 | 0.181 |
| Bun 1st ICU | 0.128 | 0.019 | 0.02 | 0.325 | 0.147 | 0.004 |
| HCT 1st ICU | −0.091 | 0.038 | – | – | −0.091 | 0.038 |
| Inotrope use arrival to ICU | 0.129 | 0.039 | – | – | 0.129 | 0.039 |
| MAP 6h ICU | −0.123 | 0.002 | – | – | −0.123 | 0.002 |
| Platelet 6h ICU | 0.119 | 0.003 | – | – | 0.119 | 0.003 |
| Pack Cell 6h ICU | 0.115 | 0.007 | – | – | 0.115 | 0.007 |
Notes.
Statistically significant (p-value < 0.05).
Figure 1Causal network diagram of influenced factors of extubation time.
(RMSEA = 0.036, CFI = 0.910, TLI = 0.901, SRMR = 0.016). ∗ The arrow indicator values are standardized direct effects with standard deviation.